This is a Validated Antibody Database (VAD) review about human BCAR3, based on 3 published articles (read how Labome selects the articles), using BCAR3 antibody in all methods. It is aimed to help Labome visitors find the most suited BCAR3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
BCAR3 synonym: AND-34; NSP2; SH2D3B; breast cancer anti-estrogen resistance protein 3; SH2 domain-containing protein 3B; breast cancer anti-estrogen resistance 3; breast cancer antiestrogen resistance 3 protein; dJ1033H22.2 (breast cancer anti-estrogen resistance 3); novel SH2-containing protein 2

Bethyl
rabbit polyclonal
  • western blot; human; fig 5a
Bethyl BCAR3 antibody (Bethly Laboratories, A301-671A) was used in western blot on human samples (fig 5a). Oncotarget (2017) ncbi
rabbit polyclonal
  • immunoprecipitation; human; fig 1
  • immunocytochemistry; human; fig 3
  • western blot; human; fig 6
Bethyl BCAR3 antibody (Bethyl, A301-671A) was used in immunoprecipitation on human samples (fig 1), in immunocytochemistry on human samples (fig 3) and in western blot on human samples (fig 6). Oncogene (2016) ncbi
rabbit polyclonal
  • western blot; human; 1:2000
Bethyl BCAR3 antibody (Bethyl Laboratories, A301-671A) was used in western blot on human samples at 1:2000. Nature (2015) ncbi
Sigma-Aldrich
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; fig 7
Sigma-Aldrich BCAR3 antibody (Sigma, HPA014858) was used in immunohistochemistry - paraffin section on human samples (fig 7). Oncogene (2016) ncbi
Articles Reviewed
  1. Coaxum S, Tiedeken J, Garrett Mayer E, Myers J, Rosenzweig S, Neskey D. The tumor suppressor capability of p53 is dependent on non-muscle myosin IIA function in head and neck cancer. Oncotarget. 2017;8:22991-23007 pubmed publisher
  2. Cross A, Wilson A, Guerrero M, Thomas K, Bachir A, Kubow K, et al. Breast cancer antiestrogen resistance 3-p130Cas interactions promote adhesion disassembly and invasion in breast cancer cells. Oncogene. 2016;35:5850-5859 pubmed publisher
  3. Konermann S, Brigham M, Trevino A, Joung J, Abudayyeh O, Bárcena C, et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature. 2015;517:583-8 pubmed publisher